Invention Grant
- Patent Title: Multifunctional quinoline derivatives as anti-neurodegenerative agents
- Patent Title (中): 多功能喹啉衍生物作为抗神经变性剂
-
Application No.: US13855311Application Date: 2013-04-02
-
Publication No.: US09302992B2Publication Date: 2016-04-05
- Inventor: Ji-Wang Chern , Chen-Wei Huang , Pei-Teh Chang , Rahul Subhash Talekar
- Applicant: ANNJI PHARMACEUTICAL CO., LTD.
- Applicant Address: TW Taipei
- Assignee: ANNJI PHARMACEUTICAL CO., LTD.
- Current Assignee: ANNJI PHARMACEUTICAL CO., LTD.
- Current Assignee Address: TW Taipei
- Agency: Intellectual Property Connections, Inc.
- Agent Hsiu-Ming Saunders
- Main IPC: C07D215/26
- IPC: C07D215/26 ; C07D215/28

Abstract:
Novel quinoline derivatives are disclosed. Also disclosed are synthesis and use thereof for treating neurodegenerative diseases. In one aspect, the invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein R1 is hydrogen, (C1-C8)alkyl, (C1-C8)alkylene(C3-C8)cycloalkyl, (C1-C8)haloalkyl, or (C1-C8)alkylene(C6-C20)aryl; R2 is hydrogen or halogen; R3 is hydrogen, halogen, (C1-C8)alkyl, or (C1-C8)alkoxy; R4 is hydrogen, halogen, (C1-C8)alkyl, (C1-C8)alkoxy, or (C1-C8)haloalkyl; R5 is hydrogen or (C1-C20)alkanol; R6 is hydrogen; and R7 is (C1-C20)alkanol, (C1-C8)alkylene (C3-C8)heterocyclyl(C1-C20)alkanol, (C1-C8)alkylene (C3-C8)heterocyclyl(C1-C20)alkyl, (C1-C8)alkylene(C1-C6)alkylamino(C1-C6)alkynyl, (C1-C8)alkyleneamino(C1-C20)alkanol, or (C1-C8)alkyleneamino(C1-C20)alkanol(C1-C8)alkylene substituted (C3-C20)heteroaryl; (II) or wherein: R1, R2, R3, R4 and R6 are each defined in (I) above; R5 is (C1-C20)alkanol; and R7 is hydrogen, (C1-C20)alkanol, (C1-C8)alkylene (C3-C8)heterocyclyl(C1-C20)alkanol, (C1-C8)alkylene (C3-C8)heterocyclyl(C1-C20)alkyl, (C1-C8)alkylene(C1-C6)alkylamino(C1-C6)alkynyl, (C1-C8)alkyleneamino(C1-C20)alkanol, or (C1-C8)alkyleneamino(C1-C20)alkanol(C1-C8)alkylene substituted (C3-C20)heteroaryl.
Public/Granted literature
- US20140296251A1 MULTIFUNCTIONAL QUINOLINE DERIVATIVES AS ANTI-NEURODEGENERATIVE AGENTS Public/Granted day:2014-10-02
Information query